A VISIONaerie™ approach
We discover, develop, and commercialize first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye
Press ReleaseAerie Pharmaceuticals Completes Enrollment of the Netarsudil... Aerie Pharmaceuticals Announces U.S. Launch of Rocklatan® and... Aerie Pharmaceuticals Matches ASCRS Foundation Fund Raising to Provide...
Jul 18, 12:12 PM ET
52 - WEEK LOW/HIGH